MEDINET CO
Cancer immuno-cell therapy is an advanced medical practice, which requires advanced knowledge in biotechnology and molecular genetics, specific technical know-how, professional cell-engineers, dedicated-use facilities with advanced safety control, particular materials and a custom-made management system for cell-culturing schedule. However, it is difficult for medical institutions to meet all of these requirements on the financial and technical aspects, and only limited numbers of medical instit... utions, such as university hospitals, are able to fulfill such requirements. Such limited numbers of medical institutions perform the immuno-cell therapy to limited number of patients for research purpose only. Therefore, it seemed that the immuno-cell therapy had not been widely used in clinical practice. In order to make the immuno-cell therapy widely available to anyone who wish to receive, MEDINET created and started providing a comprehensive solution, which includes technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy, to medical institutions.
MEDINET CO
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1995-01-01
Address:
Kahoku, Miyagi, Japan
Country:
Japan
Website Url:
http://www.medinet-inc.co.jp
Total Employee:
51+
Status:
Active
Contact:
+81454780041
Total Funding:
511.49 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Apache Mobile Non Scaleable Content Euro Cloudflare JS CDN JS
Similar Organizations
Advanced Immunotherapy
Advanced Immunotherapy is developing cancer immunotherapy using T-iPS cells.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Employees Featured
Founder
Stock Details
Investors List
Whiz Partners
Whiz Partners investment in Post-IPO Equity - Medinet Co
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2012-02-01 | REGiMMUNE | Medinet Co investment in Series C - REGiMMUNE | 5 M USD |
| 2008-09-30 | Reprocell Japan | Medinet Co investment in Corporate Round - Reprocell Japan | 21 M JPY |
Official Site Inspections
http://www.medinet-inc.co.jp Semrush global rank: 1.15 M Semrush visits lastest month: 27.61 K
- Host name: de.ptr153.ptrcloud.net
- IP address: 153.122.81.210
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
